Cellular responses to tumor necrosis factor

Current Issues in Molecular Biology

Volumn 3, Issue 4, 2001, Pages 79-90

  Liu, Z G ^a   Han, J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ETANERCEPT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; METHOTREXATE; MITOGEN ACTIVATED PROTEIN KINASE; SPHINGOMYELIN PHOSPHODIESTERASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

CELL DEATH; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; DRUG TARGETING; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOMODULATION; MOLECULAR DYNAMICS; PATHOLOGY; PHYSIOLOGY; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; CELL DEATH; HUMANS; MAP KINASE SIGNALING SYSTEM; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035157953     PISSN: 14673037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (144)

1. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial
2. A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway
3. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase
4. NF-kappaB: Ten years after
5. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
6. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
7. An essential role for NF-kappaB in preventing TNF-α-induced cell death
8. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced raw 264.7 cells
9. Tumor necrosis, cachexia, shock, and inflammation: A common mediator
10. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not
11. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death
12. Membrane-targeting of signalling molecules by SH2/SH3 domain-containing adaptor proteins
13. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin
14. An endotoxin-induced serum factor that causes necrosis of tumors
15. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: Findings in open-label and placebo-controlled trials
16. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway
17. Site-specific phosphorylation of IkappaB by a novel ubiquitination-dependent protein kinase activity
18. Apoptosis and programmed cell death in immunity
19. Signal transduction by the c-Jun N-terminal kinase
20. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha
21. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain
22. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms
23. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation
24. The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF
25. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB
26. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice
27. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs
28. Prostaglandin E2 regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1β-treated human synovial fibroblasts
29. More than one way to die: Apoptosis, necrosis and reactive oxygen damage
30. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor
31. Cell death mechanisms and the immune system
32. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity
33. Redox regulation of TNF signaling
34. Regulation of mRNA stability in mammalian cells
35. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c
36. Selective interaction of JNK protein kinase isoforms with transcription factors
37. Endotoxin-responsive sequences control cachectin/tunor necrosis factor biosynthesis at the translational level
38. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells
39. Characterization of the structure and function of a novel MAP kinase kinase (MKK6)
40. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN
41. Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-kappa B activation
42. Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I
43. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation
44. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule
45. The MAPK kinase kinase TAK1 plays a central role in coupling the interleukin-1 receptor to both transcriptional and RNA-targeted mechanisms of gene regulation
46. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappaB activation
47. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex
48. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
49. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways
50. TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors
51. Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens
52. Convergence of MAP kinase pathways on the ternary complex factor Sap-1a.X
53. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions
54. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species
55. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity
56. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal
57. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
58. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies
59. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology
60. MAPKAP kinase 2 is essential for LPS-induced TNF-a biosynthesis
61. Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice
62. Rational use of new and existing disease-modifying agents in rheumatoid arthritis
63. Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum
64. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade
65. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38
66. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice
67. Activation of the IkappaBa kinase complex by MEKK1, a kinase of the JNK pathway
68. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1
69. Deciphering the pathways of life and death
70. Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells
71. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis
72. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death
73. Cell autonomous apoptosis defects in acid sphingomyelinase knockout fibroblasts
74. MAP3K-realted kinase involved in NF-kappaB induction by TNF, CD95 and IL-1
75. IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NF-kappaB activation
76. TNF blockade in the treatment of rheumatoid arthritis: Infliximab versus etanercept
77. p493F12 kinase: A novel MAP kinase expressed in a subset of neurons in the human nervous system
78. Role of an acidic compartment in tumor-necrosis-factor-alpha-induced production of ceramide, activation of caspase-3 and apoptosis
79. The Fas death factor
80. Activation of vacuolar-type proton pumps by protein kinase C. Role in neutrophil pH regulation
81. Activation of SAPK/JNK by TNF receptor I through a noncytotoxic TRAF2-dependent pathway
82. TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses
83. The p38 signal transduction pathway: Activation and function
84. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein
85. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein
86. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
87. TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha
88. Pro-inflammatory cytokines and environmental stress cause p38 MAP kinase activation by dual phosphorylation on tyrosine and threonine
89. Identification and characterization of an IkappaB kinase
90. Mitogen-activated protein kinase pathways
91. Tumor necrosis factor receptors-structure and function
92. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor
93. TRAF2-mediated activation of NF-kappaB by TNF receptor 2 and CD40
94. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex
95. The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation
96. Long term safety of infliximab
97. TNF activates NF-kB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown
98. Stress-induced apoptosis is not mediated by endolysosomal ceramide
99. Involvement of FAN in TNF-induced apoptosis
100. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation
101. K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1
102. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL
103. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex
104. The double lives of shuttling mRNA binding proteins
105. Signal transduction by tumor necrosis factor mediated by JNK protein kinases
106. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
107. Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells
108. Lysosomal protease pathways to apoptosis: Cleavage of bid, not Pro-caspases, is the most likely route
109. Focal mesangiolysis and the pathogenesis of the Kimmelstiel-Wilson nodule
110. Apoptosis signaling
111. Recombinant human tumor necrosis factor-alpha: Effects on proliferation of normal and transformed cells in vitro
112. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: Glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK
113. Two TNF receptors
114. Fas- and tumor necrosis factor-induced apoptosis in inhibited by the poxvirus crmA gene product
115. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis
116. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines
117. Tumor necrosis factor, other cytokines and disease
118. Suppression of TNF-α-induced apoptosis by NF-kappaB
119. Inhibition of TNF-induced apoptosis by NF-kappa B
120. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
121. Induced expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects
122. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor
123. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB
124. Metaxin is required for tumor necrosis factor-induced cell death
125. Tumor necrosis factor and the therapeutic potential of anti-tumor necrosis factor antibodies
126. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
127. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling
128. Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase
129. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK
130. Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells
131. IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
132. MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration
133. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation
134. The essential role of MEKK3 in TNF-induced NF-kappaB activation
135. The IAP family: Endogenous caspase inhibitors with multiple biological activities
136. Phosphorylation of Raf by ceramide-activated protein kinase
137. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
138. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice
139. MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation
140. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IkappaB phosphorylation and NFkappaB activation
141. Liver function after renal transplantation
142. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation
143. Kinase suppressor of Ras is ceramide-activated protein kinase
144. Tumor necrosis factor α activates NF-kB in acid sphingomyelinase-deficient mouse embryonic fibroblasts